BDRL yields 22909.51% · JNJ yields 2.13%● Live data
📍 BDRL pulled ahead of the other in Year 1
Combined, BDRL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BDRL + JNJ for your $10,000?
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders. The company also provides NXG IP digital video processing and headend products, including IPTV format conversions and simulcast use cases. In addition, it offers coax distribution products comprising broadband amplifiers, directional taps, splitters, and wall outlets; coax distribution products are either mounted on exterior utility poles or encased in pedestals, vaults, or other security devices in cable television systems; distribution system is enclosed within the walls of the building or added to an existing structure using various techniques to hide the coax cable and devices in SMB systems; and non-passive devices for signal distributed from the headend is of sufficient strength when it arrives at its final destination to provide audio/video images. Further, the company provides CPE products consisting of Android-based IPTV set top boxes. Additionally, it offers digital modulation products, such as Aircastertm ATSC, QAM, and IP trans-modulator series of products allow the user to create a line up from off-air and/or cable feeds for coax IP distribution; Edge QAM devices that accept Ethernet input and capture MPEG over IP transport streams, decrypt service provider conditional access or content protection, and insert proprietary conditional access; DOCSIS data products; service level agreements and services; and analog modulation, fiber, and miscellaneous products and services, as well as test and measurement instruments, and contract manufacturing services. The company was founded in 1950 and is headquartered in Old Bridge, New Jersey.
Full BDRL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.